JNS001

· Janssen Pharmaceutical K.K.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JNS001, covering 2013-09-06 to 2014-03-28. Get the full timeline:

Most recent: Clinical Trial Update: A Long-Term Study on Safety of JNS001 in Adults With Attention-Deficit Hyperactivity Disorder [Phase 3]